10x Genomics (TXG) News Today $10.90 -0.66 (-5.71%) Closing price 04:00 PM EasternExtended Trading$10.98 +0.07 (+0.69%) As of 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Alberta Investment Management Corp Makes New $3.21 Million Investment in 10x Genomics, Inc. (NASDAQ:TXG)Alberta Investment Management Corp acquired a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 223,280 shares of the company's stock, valued at apFebruary 21 at 4:28 AM | marketbeat.com10x Genomics' (TXG) Sell (E+) Rating Reiterated at Weiss RatingsFebruary 20 at 3:11 AM | americanbankingnews.comWeiss Ratings Reiterates Sell (E+) Rating for 10x Genomics (NASDAQ:TXG)Weiss Ratings reaffirmed a "sell (e+)" rating on shares of 10x Genomics in a report on Wednesday.February 20 at 2:36 AM | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Given Consensus Recommendation of "Hold" by BrokeragesShares of 10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) have been given an average recommendation of "Hold" by the seventeen brokerages that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven havFebruary 19 at 2:36 AM | marketbeat.com10x Genomics to Participate in the 45th Annual TD Cowen Health Care ConferenceFebruary 18 at 4:05 PM | prnewswire.com10x Genomics (TXG) Expected to Announce Quarterly Earnings on ThursdayFebruary 18 at 2:51 AM | americanbankingnews.comQ1 EPS Estimates for 10x Genomics Reduced by Leerink PartnrsFebruary 18 at 1:19 AM | americanbankingnews.comMorgan Stanley Cuts 10x Genomics (NASDAQ:TXG) Price Target to $26.00February 17, 2025 | americanbankingnews.comBrokers Issue Forecasts for 10x Genomics Q3 EarningsFebruary 17, 2025 | americanbankingnews.comWilliam Blair Estimates 10x Genomics Q3 Earnings10x Genomics, Inc. (NASDAQ:TXG - Free Report) - Research analysts at William Blair issued their Q3 2025 earnings per share (EPS) estimates for 10x Genomics in a research report issued to clients and investors on Thursday, February 13th. William Blair analyst M. Larew anticipates that the companyFebruary 17, 2025 | marketbeat.comLeerink Partnrs Lowers Earnings Estimates for 10x Genomics10x Genomics, Inc. (NASDAQ:TXG - Free Report) - Leerink Partnrs dropped their Q1 2025 earnings per share estimates for 10x Genomics in a research report issued to clients and investors on Thursday, February 13th. Leerink Partnrs analyst P. Souda now anticipates that the company will post earningsFebruary 17, 2025 | marketbeat.comStifel Nicolaus Has Lowered Expectations for 10x Genomics (NASDAQ:TXG) Stock PriceFebruary 16, 2025 | americanbankingnews.com10x Genomics (NASDAQ:TXG) Cut to Market Perform at Leerink PartnersFebruary 16, 2025 | americanbankingnews.comJPMorgan Chase & Co. Cuts 10x Genomics (NASDAQ:TXG) Price Target to $12.00February 16, 2025 | americanbankingnews.comLeerink Partnrs Downgrades 10x Genomics (NASDAQ:TXG) to HoldFebruary 16, 2025 | americanbankingnews.com10x Genomics (NASDAQ:TXG) Shares Up 8.3% - Here's Why10x Genomics (NASDAQ:TXG) Stock Price Up 8.3% - Time to Buy?February 15, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Price Target Cut to $26.00 by Analysts at Morgan StanleyMorgan Stanley reduced their price target on shares of 10x Genomics from $28.00 to $26.00 and set an "overweight" rating on the stock in a research report on Friday.February 15, 2025 | marketbeat.comLeerink Partnrs Forecasts 10x Genomics Q1 Earnings10x Genomics, Inc. (NASDAQ:TXG - Free Report) - Leerink Partnrs issued their Q1 2026 EPS estimates for 10x Genomics in a research report issued on Thursday, February 13th. Leerink Partnrs analyst P. Souda anticipates that the company will post earnings of ($0.35) per share for the quarter. LeerinFebruary 15, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Lowered to "Hold" Rating by Leerink PartnrsLeerink Partnrs cut 10x Genomics from a "strong-buy" rating to a "hold" rating in a report on Thursday.February 15, 2025 | marketbeat.comCitigroup Cuts 10x Genomics (NASDAQ:TXG) Price Target to $20.00February 15, 2025 | americanbankingnews.comAnalysts Issue Forecasts for 10x Genomics Q1 EarningsFebruary 15, 2025 | americanbankingnews.com10x Genomics (NASDAQ:TXG) Given New $14.00 Price Target at UBS GroupFebruary 15, 2025 | americanbankingnews.com10x Genomics (NASDAQ:TXG) Given New $18.00 Price Target at Canaccord Genuity GroupFebruary 15, 2025 | americanbankingnews.comCanaccord Genuity Group Has Lowered Expectations for 10x Genomics (NASDAQ:TXG) Stock PriceCanaccord Genuity Group reduced their target price on 10x Genomics from $20.00 to $18.00 and set a "buy" rating for the company in a research note on Thursday.February 14, 2025 | marketbeat.com10x Genomics Full Year 2024 Earnings: EPS Misses ExpectationsFebruary 14, 2025 | finance.yahoo.com10x Genomics price target lowered to $15 from $18 at BarclaysFebruary 14, 2025 | markets.businessinsider.com10x Genomics (TXG) Receives a Buy from Morgan StanleyFebruary 14, 2025 | markets.businessinsider.comLeerink Partners Downgrades 10x Genomics (TXG)February 14, 2025 | msn.com10x Genomics price target lowered to $18 from $21 at StifelFebruary 13, 2025 | markets.businessinsider.comLife Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding UncertaintiesFebruary 13, 2025 | uk.finance.yahoo.com10x Genomics price target lowered to $12 from $14 at JPMorganFebruary 13, 2025 | markets.businessinsider.comWhy 10x Genomics (TXG) Shares Are Falling TodayFebruary 13, 2025 | msn.com10x Genomics (NASDAQ:TXG) Price Target Lowered to $20.00 at CitigroupCitigroup lowered their target price on 10x Genomics from $23.00 to $20.00 and set a "buy" rating for the company in a research note on Thursday.February 13, 2025 | marketbeat.com10x Genomics, Inc.: 10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025February 13, 2025 | finanznachrichten.de10x Genomics price target lowered to $16 from $20 at BofAFebruary 13, 2025 | markets.businessinsider.com10x Genomics (NASDAQ:TXG) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses ExpectationsFebruary 13, 2025 | msn.com10x Genomics price target lowered to $15 from $18 at TD CowenFebruary 13, 2025 | markets.businessinsider.com10x Genomics, Inc. (NASDAQ:TXG) Q4 2024 Earnings Call TranscriptFebruary 13, 2025 | msn.com10x Genomics (NASDAQ:TXG) Price Target Cut to $12.00 by Analysts at JPMorgan Chase & Co.JPMorgan Chase & Co. cut their target price on shares of 10x Genomics from $14.00 to $12.00 and set a "neutral" rating on the stock in a research report on Thursday.February 13, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Shares Gap Down on Disappointing Earnings10x Genomics (NASDAQ:TXG) Shares Gap Down After Earnings MissFebruary 13, 2025 | marketbeat.comUBS Group Cuts 10x Genomics (NASDAQ:TXG) Price Target to $14.00UBS Group decreased their target price on shares of 10x Genomics from $20.00 to $14.00 and set a "neutral" rating for the company in a research report on Thursday.February 13, 2025 | marketbeat.comStifel Nicolaus Issues Pessimistic Forecast for 10x Genomics (NASDAQ:TXG) Stock PriceStifel Nicolaus decreased their price target on shares of 10x Genomics from $21.00 to $18.00 and set a "buy" rating on the stock in a report on Thursday.February 13, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Rating Lowered to "Market Perform" at Leerink PartnersLeerink Partners lowered 10x Genomics from an "outperform" rating to a "market perform" rating and dropped their price target for the company from $25.00 to $12.00 in a research note on Thursday.February 13, 2025 | marketbeat.comEntropy Technologies LP Grows Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)Entropy Technologies LP raised its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 285.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 37,595 shares of the company's stock after acquiring an additional 27February 13, 2025 | marketbeat.com10x Genomics (TXG) Projected to Post Quarterly Earnings on Thursday10x Genomics (NASDAQ:TXG) will be releasing earnings after the market closes on Thursday, February 20, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=659960)February 13, 2025 | marketbeat.com10x Genomics, Inc. (TXG) Q4 2024 Earnings Call TranscriptFebruary 12, 2025 | seekingalpha.com10x Genomics (NASDAQ:TXG) Releases Quarterly Earnings Results, Misses Expectations By $0.08 EPS10x Genomics (NASDAQ:TXG - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.40) earnings per share for the quarter, missing analysts' consensus estimates of ($0.32) by ($0.08). 10x Genomics had a negative net margin of 28.93% and a negative return on equity of 25.07%.February 12, 2025 | marketbeat.com10x Genomics reports Q4 EPS (40c), consensus (11c)February 12, 2025 | markets.businessinsider.com10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025February 12, 2025 | prnewswire.com10X Genomics stock plunges to 52-week low of $11.89February 11, 2025 | msn.com Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address TXG Media Mentions By Week TXG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TXG News Sentiment▼0.150.60▲Average Medical News Sentiment TXG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TXG Articles This Week▼367▲TXG Articles Average Week Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Vontier News Sensata Technologies News Camtek News Mirion Technologies News Transcat News Senseonics News Cytek Biosciences News Standard BioTools News Allient News EyePoint Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TXG) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 10x Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 10x Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TXG Stock Alerts